This content is machine translated Mucinoses Phenomenology of a clinical picture Mucin deposits are possible in all skin layers, and the site of deposition is not pathognomonic. In addition to primary mucinosis, this deposition dermatosis often manifests as an epiphenomenon. The…
View Post 7 min This content is machine translated Chronic inflammatory bowel disease Therapy in transition: innovation through biologics In treatment-resistant severe cases, a biologic representative of a new substance class, vedolizumab, is now available in addition to conventional standard medication and anti-TNFα. Several evaluations of different therapies from…
View Post 3 min This content is machine translated Psoriasis Outlook on possible future therapy options As part of this year’s AAD, several speakers reported on on research-stage antipsoriatic agents, which showed promising results in phase 2 trials. Biologics and tyrosine kinase 2 inhibitors are among…
View Post 2 min This content is machine translated Big Data in Cardiology Medicine 4.0 – the digital transformation in hypertensive patients Big data, artificial intelligence, Medicine 4.0 – digitization is not stopping at medicine. Digital medical technology will determine more and more medical activities and thus also change the role of…
View Post 7 min This content is machine translated Modern psoriasis management Biologics, conventional systemic therapy or local treatment? Given the wide variety of targeted treatment options available today, evidence-based criteria are an important toolkit. International experts spoke on this topic at the SGDV Annual Meeting.
View Post 3 min This content is machine translated New guidelines Global science at first hand At the annual meeting of the European Society of Cardiology (ESC) this year, in addition to the latest scientific findings, five new guidelines were presented on diabetes, acute pulmonary embolism,…
View Post 3 min This content is machine translated Ovarian Cancer Improved PFS argues for maintenance therapy with PARP inhibitor More women die from ovarian cancer than from any other tumor – mainly because it is usually detected very late. PARP inhibitors have been developed for the treatment of recurrent…
View Post 5 min This content is machine translated Type 2 diabetes Multifactorial goal-directed therapy for under-50s. Type 2 diabetes often develops insidiously and over a long period of time. In those under 50, metabolic syndrome is often associated. Special attention should be paid to cardiovascular risk…
View Post 4 min This content is machine translated Atopic dermatitis Empirical data with dupilumab confirm the empirical evidence The biologic Dupilumab has proven itself under “real-life” conditions and has already received an extension of approval in the EU for the age group 12 years and older. At the…
View Post 6 min This content is machine translated Pediatric Rheumatology Always puncture joints! In treatment-resistant severe cases, a biologic representative of a new class of substances is available. Several evaluations of different forms of therapy came up with exciting results. One study made…
View Post 1 min This content is machine translated Squamous cell carcinoma Pembrolizumab as first-line therapy reduces mortality rate In a phase III trial, pembrolizumab improved overall survival in patients with recurrent or metastatic head and neck squamous cell carcinoma.
